ARGX Trading Analysis - 10/23/2026 04:45 PM — TRU-SENTIMENT

ARGX (argenx SE American Depositary Shares) at $874.74. True Sentiment Bullish, delta 40-60 call 75% / put 25%, call $217,520 vs put $70,990. RSI 43.2.

TRU-SENTIMENT · DeltaNeutral

ARGX Trading Analysis - 10/23/2026 04:45 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

ARGX (argenx SE American Depositary Shares) at $874.74. True Sentiment Bullish, delta 40-60 call 75% / put 25%, call $217,520 vs put $70,990. RSI 43.2.

Symbol
ARGX
Price
$874.74
Article bias (separate from True Sentiment)
bullish
Conviction
low
Published
2026-10-23 16:45:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-10-23) filtered to delta 40-60: Call dollar vol 217,520.00 (75.40%), Put dollar vol 70,990.00 (24.60%), total 288,510.00. Sentiment: Bullish. Contracts: 37 calls / 10 puts. Pure directional conviction skews call-heavy. Divergence: technicals bearish (price < SMA50, MACD negative) vs sentiment bullish – confirmed by spread engine: "Divergence detected between technical indicators and options sentiment."

Call Volume: 217,520.00 (75.40%) Put Volume: 70,990.00 (24.60%) Total: 288,510.00

Key Statistics: ARGX

$873.71 -0.83%
52-Week Range
$661.85 - $1,072.75
Market Cap
$54.94B
P/E (TTM)
31.30
PEG Ratio
N/A
Beta
0.33
Next Earnings
N/A
Avg Volume
$299,888
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)31.30
EPS (trailing 12 mo)$27.75
Market cap$54.94B
Shares outstanding62.9M

Dividend

Dividend yield0.00%

Risk & range

Beta0.33
52-week low$661.85
52-week high$1,072.75
Historical volatility46.9%

Ownership & trading

Institutional ownership37.9%
Average daily volume0.5M sh

Reported figures; no analyst estimates.

📈 Analysis

News Headlines & Context

The following items are based on general knowledge of argenx (ARGX) and are separated from the data-driven analysis below:

  • argenx reported positive Phase 3 data for efgartigimod in myositis earlier in 2026, reinforcing its immunology pipeline strength.
  • The company presented at a major European hematology conference in October 2026, highlighting expanding indications for Vyvgart.
  • No near-term earnings date was flagged in the provided data; next catalyst watch is on regulatory updates and U.S. uptake metrics.
  • Broad biotech sector stabilized in Q4 2026 after a volatile September shelf-off, which may contextualize the October rebound attempt.
  • Headlines suggest fundamental optimism, but the embedded technical data shows a stock still recovering from an early-October gap-down.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for ARGX (as of 2026-10-23):

MetricValue
Trailing P/E31.30
Trailing EPS27.75
Market Cap54,943,812,630.00
Shares Outstanding62,886,000.00
Dividend Yield0.00
Beta0.33
52-Week High1072.75
52-Week Low661.85
Institutional %37.91
Average Volume474,000.00
Historical Volatility46.90

Revenue growth (YoY), gross/operating/net margins, ROE, Debt/Equity, and Free Cash Flow are not provided (null). PEG ratio is null; trailing P/E of 31.30 is the only valuation anchor and is moderate for a biotech with no dividend. Analyst consensus and target mean price are null. Fundamentals show a large-cap (54.94B) profitable shell (EPS 27.75) with low beta (0.33) and modest institutional ownership (37.91%). The provided data lacks growth/margin detail, so fundamental alignment with the bearish technical picture (price below SMA50) cannot be confirmed beyond stable earnings and low systemic risk.

Current Market Position

Current price from indicators: 875.14 (2026-10-23 close per daily: 875.14). Recent daily action: 2026-10-08 gap-down to 821.63 on volume 2,260,048; recovery to 890.35 on 2026-10-21; pullback to 875.14 on 2026-10-23. Minute bars (2026-10-22 open 853.28, high 897.27, close 881.00; 2026-10-23 last bar close 874.74, low 874.74) show intraday drift lower into close.

Support
865.72
Resistance
897.27
20d SMA
881.54
30d High
1008.32
30d Low
787.73

Technical Analysis

Technical Indicators

RSI (14)
43.16
MACD
-23.53 / Sig -18.83
SMA 5
868.71
SMA 20
881.54
SMA 50
953.55
Bollinger Mid
881.54
Bollinger Up
992.53
Bollinger Lo
770.55
ATR 14
37.51

SMA alignment: Price (875.14) > SMA5 (868.71) but < SMA20 (881.54) and < SMA50 (953.55) – bearish stack, no golden cross. RSI 43.16 = neutral-weak momentum. MACD histogram -4.71 (bearish). Bollinger: price near lower-middle, no squeeze (range 770.55–992.53). 30d range high 1008.32, low 787.73; current 875.14 is 36.7% above low, 13.2% below high.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-10-23) filtered to delta 40-60: Call dollar vol 217,520.00 (75.40%), Put dollar vol 70,990.00 (24.60%), total 288,510.00. Sentiment: Bullish. Contracts: 37 calls / 10 puts. Pure directional conviction skews call-heavy. Divergence: technicals bearish (price < SMA50, MACD negative) vs sentiment bullish – confirmed by spread engine: "Divergence detected between technical indicators and options sentiment."

Call Volume: 217,520.00 (75.40%) Put Volume: 70,990.00 (24.60%) Total: 288,510.00

Key Price Levels (Observational Only)

Daily Low 10-23
865.72
Daily High 10-22
897.27
Bollinger Lower
770.55
SMA 50
953.55

Interactive charts load with JavaScript. This text is the crawlable summary.